Shadow

Tag: AT100

Corona Treatment: Vaccines/drugs in the pipeline for COVID-19-updated

Corona Treatment: Vaccines/drugs in the pipeline for COVID-19-updated

Medicospace Blog
Coronavirus vaccine by Medicago Medicago is developing drug candidates against COVID-19 after having produced Virus-Like Particles (VLP) of the coronavirus. The company has formed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2. The company’s research activities are being partly funded by the Canadian Institutes for Health Research (CIHR). AT-100 by Airway Therapeutics Airway Therapeutics is exploring its novel human recombinant protein named AT-100 (rhSP-D) as a treatment for coronavirus. The company has announced a filing with the Respiratory Diseases Branch of the National Institutes of Health to evaluate the drug. AT-100 has shown efficacy in preclinical studies in reducing inflammation and infection in the lung...